[Federal Register: January 29, 1999 (Volume 64, Number 19)] [Notices] [Page 4664] From the Federal Register Online via GPO Access [wais.access.gpo.gov] [DOCID:fr29ja99-72] ======================================================================= ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Office of the Secretary Findings of Scientific Misconduct AGENCY: Office of the Secretary, HHS. ACTION: Notice. ----------------------------------------------------------------------- SUMMARY: Notice is hereby given that the Office of Research Integrity (ORI) has made a final finding of scientific misconduct in the following case: Ms. Nellie Briggs-Brown, Rush-Presbyterian-St. Luke's Medical Center: Based on the report of an investigation conducted by Rush- Presbyterian-St. Luke's Medical Center dated December 3, 1997, ORI finds that Ms. Briggs Brown, former employee, Department of Neurology, engaged in scientific misconduct in clinical research supported by two National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH) grants. Specifically, Ms. Briggs-Brown (1) falsified seven monthly screening logs for a NINDS funded study involving stroke victims (Randomized Trial of Org 10172 in Acute Ischemic Stroke Treatment) and submitted the same logs with altered dates on multiple occasions to the University of Iowa Coordinating Center; and (2) falsified several Human Investigation Committee research approval forms. None of the questioned data has been included in publications. ORI has implemented the following administrative actions for the three (3) year period beginning January 25, 1999: (1) Ms. Briggs-Brown is prohibited from serving in any advisory capacity to PHS, including but not limited to service on any PHS advisory committee, board, and/or peer review committee, or as a consultant; and (2) Any institution that submits an application for PHS support for a research project on which Ms. Briggs-Brown's participation is proposed or which uses her in any capacity on PHS supported research, or that submits a report of PHS-funded research in which she is involved, must concurrently submit a plan for supervision of her duties to the funding agency for approval. The supervisory plan must be designed to ensure the scientific integrity of Ms. Briggs-Brown's research contribution. The institution also must submit a copy of the supervisory plan to ORI. FOR FURTHER INFORMATION CONTACT: Acting Director, Division of Research Investigations, Office of Research Integrity, 5515 Security Lane, Suite 700, Rockville, MD 20852, (301) 443-5330. Chris B. Pascal, Acting Director, Office of Research Integrity. [FR Doc. 99-2158 Filed 1-28-99; 8:45 am] BILLING CODE 4160-17-P